Stein Hallan|Josef Coresh|Brad C. Astor|Arne A[Combining Ring Above]sberg|Neil R. Powe|Solfrid Romundstad|Hans Hallan|Stian Lydersen|Jostein Holmen
International Comparison of the Relationship of Chronic Kidney Disease Prevalence and ESRD Risk
Norwegian University of Science and Technology|Johns Hopkins Medicine|Johns Hopkins University|Welch Foundation|Johns Hopkins University|Welch Foundation|St Olav's University Hospital|Johns Hopkins Medicine|Johns Hopkins University|Welch Foundation|Norwegian University of Science and Technology|Levanger Hospital|Levanger Hospital|Norwegian University of Science and Technology|Norwegian University of Science and Technology
esrd incidence much lower europe compared united states study investigated whether reflects difference prevalence earlier stages chronic kidney disease ckd mechanisms ckd prevalence norway estimated populationbased health survey nordtrondelag county hunt ii included 65181 adults 1995 1997 participation rate 704 data analyzed using methods two us national health nutrition examination surveys 1988 1994 n 15488 1999 2000 n 4101 primary analysis used genderspecific cutoffs estimating persistent albuminuria ckd stages 1 2 esrd rates relevant data extracted national registries total ckd prevalence norway 102 se 05 ckd stage 1 gfr 90 mlmin per 173 m2 albuminuria 27 se 03 stage 2 gfr 60 89 mlmin per 173 m2 albuminuria 32 se 04 stage 3 gfr 30 59 mlmin per 173 m2 42 se 01 stage 4 gfr 15 29 mlmin per 173 m2 02 se 001 closely approximates reported us ckd prevalence 110 1988 1994 117 1999 2000 relative risk progression ckd stages 3 4 esrd us white patients compared norwegian patients 25 modestly modified adjustment age gender diabetes age gfr start dialysis similar hypertension cardiovascular mortality populations comparable us white patients referred later nephrologist higher prevalence obesity diabetes conclusion ckd prevalence norway similar united states suggesting lower progression esrd rather smaller pool individuals risk accounts lower incidence esrd norway